Fasciola hepatica (F. hepatica) is a well-known zoonotic parasite that is crucial for economic and public health worldwide. Quantitative proteomics studies have been performed on proteins expressed by F. hepatica to investigate the differential expression of proteomes in different growth phases. And the screening of several marker proteins for use as early diagnostic antigens is essential. In this study, high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) was conducted to analyze the differences in the expression of F. hepatica somatic proteins in different growth phases. Furthermore, gene ontology (GO) functional annotation, KEGG metabolic pathway, and clustering analyses were also performed. LC-MS/MS identified 629, 2286, 2254, and 2192 proteins in metacercariae, juvenile flukes 28dpi, immature flukes 59dpi, and adult phases, respectively. GO analysis revealed that differentially expressed proteins (DEPs) were mainly involved in transport, localization, metabolism, enzyme regulation, protein folding and binding, and nucleoside and nucleotide binding. The DEPs were enriched in cells, intracellular components, organelles, cytoplasm, vesicles, and membranes. KEGG pathway annotation results showed that the DEPs were involved in metabolism, genetic information processing, environmental information processing, cellular processes, organismal systems, and other processes. These findings provide a theoretical basis for vaccine development and establishing early diagnostic methods in the future.By measuring the cerebral infarction rate and neurological behavioral score of rats in a sham operation group, an MCAO model control group and an Erigeron breviscapus injection treatment group, we explored the therapeutic effects of Erigeron breviscapus injection on brain tissue and neuroethological injury in rats. Plasma samples were collected at 18 time points after intravenous injection of Erigeron breviscapus. The levels of scutellarin, 4-caffeoylquinic acid, 5-caffeoylquinic acid, 3,5-dicaffeoylquinic acid, 4,5-dicaffeoylquinic acid, chlorogenic acid and isochlorogenic acid B in rat plasma at the various time points were determined by an HPLC method, and drug concentration versus time plots were constructed to estimate the pharmacokinetic parameters. Finally, a PK-PD combined model was used to analyze the relationship between the blood concentration, time and therapeutic effects of the seven active components. The results of the pharmacodynamics studies showed that the cerebral infarction rate of rats ingeron breviscapus injection group were significantly reduced, with decreased values of 6.22%, 11.71%, 6.92% and 4.96%, respectively, and the effects were stronger than those after 5-20 min of cerebral ischemia. The decreased values reached their highest value after 24 h of cerebral ischemia. Our results show that the effects of Erigeron breviscapus injection on reducing the cerebral infarct rate in MCAO model rats are characterized by a fast onset and long maintenance time. The 5-min blood concentration in cerebral ischemia was the highest test value, and after this time, the cerebral infarction rate of MCAO rats began to decrease. However, the peak value of the effects lagged behind that of the plasma concentration. The maximum effective time for Erigeron breviscapus injection appeared 24 h after cerebral ischemia, which provides a reference for the screening of specific drugs for ischemic stroke, optimal dosing regimens and rational clinical drug use. Graphical Abstract.Atypical vascular proliferations (AVP) are a late complication after radiotherapy. Most cases have been reported in female breast cancer patients on the chest wall. These lesions are mostly of the lymphatic type. Herein, we report a blood vascular-type AVP in a male on the neck 60 years after radiotherapy for a benign hemangioma, which makes this case exceptional. We removed the whole chronic radiodermatitis surgically. Histopathology excluded vascular malignancies but confirmed AVP. We discuss the differential diagnoses and treatment.

Preoperative risk stratification, patient optimization and anesthesia disclosure are mostly carried out in the preanesthesia outpatient department in a direct conversation between physician and patient. The aim of this article is a description of the preanesthesia telephone contact as an alternative disclosure and clarification option for the clinical practice.

After clarification of data protection and medicolegal aspects, experiences with providing information via telephone in a single center were gathered.

Initially, before spinal operations pain patients with unreasonably long access routes to the preanesthesia outpatient department received clarification and disclosure via the telephone. Due to the effectiveness and the lack of medical and processual complications, after 1 year the offer of a telephone conversation was extended to all patients. In the meantime, 47% of preanesthesia conversations are now carried out by telephone. Factors relevant for success are the consent of the patient to a telephone conversation, a multimedia patient education before the telephone conversation, competence of the anesthetist in communication, documentation and a clearly defined description of the process including changeover to the direct conversation.

The preanesthesia telephone conversation is suitable as an alternative to the preanesthesia conversation in the outpatient department. selleck High patient satisfaction results from the patient-oriented process, avoidance of transportation routes and the participative communication.

The preanesthesia telephone conversation is suitable as an alternative to the preanesthesia conversation in the outpatient department. High patient satisfaction results from the patient-oriented process, avoidance of transportation routes and the participative communication.Humans evaluate other agents’ behavior on a variety of different dimensions, including morally, from a very early age. For example, human infants as young as 6-months old prefer prosocial over antisocial others and demonstrate negative evaluations of antisocial others in a variety of paradigms (Hamlin et al. in Nature 450(7169)557, 2007; Dev Sci 13(6)923-929, 2010; Proc Natl Acad Sci 108(50)19931-19936, 2011). While these tendencies are well documented in the human species, less is known about whether similar preference emerge in non-human animals. Here, we explore this question by testing prosocial preferences in one non-human species the domestic dog (Canis lupus familiaris). Given the ubiquity of dog-human social interactions, it is possible that dogs display human-like social evaluation tendencies. Unfortunately, prior research examining social evaluation in dogs has produced mixed results. To assess whether differences in methodology or training differences account for these contrasting results, we tested two samples of dogs with different training histories on an identical social evaluation task.